Krabbe Disease: Prospects of Finding a Cure Using AAV Gene Therapy
Krabbe Disease (KD) is an autosomal metabolic disorder that affects both the central and peripheral nervous systems. It is caused by a functional deficiency of the lysosomal enzyme, galactocerebrosidase (GALC), resulting in an accumulation of the toxic metabolite, psychosine. Psychosine accumulation...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/075dde463a2647d8bec66eeb56a8de50 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:075dde463a2647d8bec66eeb56a8de50 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:075dde463a2647d8bec66eeb56a8de502021-11-12T13:24:16ZKrabbe Disease: Prospects of Finding a Cure Using AAV Gene Therapy2296-858X10.3389/fmed.2021.760236https://doaj.org/article/075dde463a2647d8bec66eeb56a8de502021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmed.2021.760236/fullhttps://doaj.org/toc/2296-858XKrabbe Disease (KD) is an autosomal metabolic disorder that affects both the central and peripheral nervous systems. It is caused by a functional deficiency of the lysosomal enzyme, galactocerebrosidase (GALC), resulting in an accumulation of the toxic metabolite, psychosine. Psychosine accumulation affects many different cellular pathways, leading to severe demyelination. Although there is currently no effective therapy for Krabbe disease, recent gene therapy-based approaches in animal models have indicated a promising outlook for clinical treatment. This review highlights recent findings in the pathogenesis of Krabbe disease, and evaluates AAV-based gene therapy as a promising strategy for treating this devastating pediatric disease.Gibran NasirRajiv ChopraFiona ElwoodSeemin S. AhmedFrontiers Media S.A.articleKrabbe disease (globoid cell leukodystrophy)leukodystrophiesadeno-associated virusgene therapygalactocerebrosidasepsychosineMedicine (General)R5-920ENFrontiers in Medicine, Vol 8 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Krabbe disease (globoid cell leukodystrophy) leukodystrophies adeno-associated virus gene therapy galactocerebrosidase psychosine Medicine (General) R5-920 |
spellingShingle |
Krabbe disease (globoid cell leukodystrophy) leukodystrophies adeno-associated virus gene therapy galactocerebrosidase psychosine Medicine (General) R5-920 Gibran Nasir Rajiv Chopra Fiona Elwood Seemin S. Ahmed Krabbe Disease: Prospects of Finding a Cure Using AAV Gene Therapy |
description |
Krabbe Disease (KD) is an autosomal metabolic disorder that affects both the central and peripheral nervous systems. It is caused by a functional deficiency of the lysosomal enzyme, galactocerebrosidase (GALC), resulting in an accumulation of the toxic metabolite, psychosine. Psychosine accumulation affects many different cellular pathways, leading to severe demyelination. Although there is currently no effective therapy for Krabbe disease, recent gene therapy-based approaches in animal models have indicated a promising outlook for clinical treatment. This review highlights recent findings in the pathogenesis of Krabbe disease, and evaluates AAV-based gene therapy as a promising strategy for treating this devastating pediatric disease. |
format |
article |
author |
Gibran Nasir Rajiv Chopra Fiona Elwood Seemin S. Ahmed |
author_facet |
Gibran Nasir Rajiv Chopra Fiona Elwood Seemin S. Ahmed |
author_sort |
Gibran Nasir |
title |
Krabbe Disease: Prospects of Finding a Cure Using AAV Gene Therapy |
title_short |
Krabbe Disease: Prospects of Finding a Cure Using AAV Gene Therapy |
title_full |
Krabbe Disease: Prospects of Finding a Cure Using AAV Gene Therapy |
title_fullStr |
Krabbe Disease: Prospects of Finding a Cure Using AAV Gene Therapy |
title_full_unstemmed |
Krabbe Disease: Prospects of Finding a Cure Using AAV Gene Therapy |
title_sort |
krabbe disease: prospects of finding a cure using aav gene therapy |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/075dde463a2647d8bec66eeb56a8de50 |
work_keys_str_mv |
AT gibrannasir krabbediseaseprospectsoffindingacureusingaavgenetherapy AT rajivchopra krabbediseaseprospectsoffindingacureusingaavgenetherapy AT fionaelwood krabbediseaseprospectsoffindingacureusingaavgenetherapy AT seeminsahmed krabbediseaseprospectsoffindingacureusingaavgenetherapy |
_version_ |
1718430413391659008 |